Clinical and Histomorphometric Analysis of Collagen Matrix Versus Connective Tissue Graft in Mucogingival Surgery in Orthodontic Patients

Sponsor
Elena Ruiz de Gopegui Palacios (Other)
Overall Status
Unknown status
CT.gov ID
NCT03533933
Collaborator
(none)
5
1
2
45
0.1

Study Details

Study Description

Brief Summary

There are some orthodontics treatments that perform risk movements ,and a bone dehiscence may be expected. In that cases mucogingival surgery , such as connective tissue grafts, is necessary prior to tooth movement.

The connective tissue graft in combination with coronal advanced flap is still considered the gold standard , although the use of porcine collagen matrix has obtained promising results for treatment of Miller class I and II recession defects.

Most of the studies report clinical results after a connective tissue graft and there is no evidence about the type of attachment obtained after the graft is performed, a few articles have shown histological results. But, as a rule , a histological study is only performed under exceptional circumstances such as a dental fracture, untreatable decay, tooth extraction for orthodontic reasons, or other reasons.

Most of the techniques results in the formation of a long junctional epithelium and connective tissue attachment with fibers parallel to the root surface. Animals studies have shown a shorter epithelium and a larger new cementum formation after the use of the collagen matrix.

Condition or Disease Intervention/Treatment Phase
  • Device: Collagen matrix
  • Other: autologous connective tissue graft
N/A

Detailed Description

The purpose of this study is to confirm that periodontal regeneration happens after mucogingival surgery The principal outcome is compare the millimeters of new attachment create after a connective tissue graft and after the use of a porcine collagen matrix in teeth that have to been extracted (because of the orthodontic planing treatment) after mucogingival surgery .

The secondary outcomes are:
  1. length of new cementum (histometry results)

  2. length of the junctional epithelium (histometry results)

  3. length of connective tissue attachment (histometry results)

  4. complete root coverage (clinical results)

  5. width of keratinized tissue

Study Design

Study Type:
Interventional
Anticipated Enrollment :
5 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Split mouthSplit mouth
Masking:
Single (Outcomes Assessor)
Masking Description:
Analyst and Histometry: The statistician and the pathologist does not know which treatment corresponds to each variable.
Primary Purpose:
Treatment
Official Title:
Clinical and Histomorphometric Analysis of Collagen Matrix Versus Connective Tissue Graft in Mucogingival Surgery in Orthodontic Patients. A Randomized, Controlled Clinical Trial
Actual Study Start Date :
Sep 1, 2018
Anticipated Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Autologous connective tissue graft

Soft tissue harvesting from patient palate

Other: autologous connective tissue graft
Soft tissue harvesting from patient palate with coronal advanced flap

Experimental: collagen matrix

Mucograft collagen matrix manufactured by Geistlich AG, Switzerland Device: Collagen matrix

Device: Collagen matrix
Mucograft collagen matrix combined with coronal advanced flap

Outcome Measures

Primary Outcome Measures

  1. millimeters of new attachment [Change from baseline at following surgery sixth month]

    histometry assessment

Secondary Outcome Measures

  1. Length of new cementum [Change from baseline at following surgery sixth month]

    histometry assessment

  2. Length of new junctional epithelium [Change from baseline at following surgery sixth month]

    histometry assessment

  3. length of connective attachment [Change from baseline at following surgery sixth month]

    histometry assessment

  4. complete root coverage [Change from baseline at following surgery sixth month]

    clinical assessment

  5. width of keratinized tissue [Change from baseline at following surgery sixth month]

    clinical assessment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patient in orthodontic treatment ,who needs mucogingival surgery in both hemi arcade and later the tooth adjacent to the graft should be extracted because of the orthodontic planing treatment .

  • The patient must be 18 years or older

  • Patient shows sufficient plaque control (FMPS < 20%).

  • The patient is able to fully understand the nature of the proposed surgery and is able to provide a signed informed consent

Exclusion Criteria:
  • General contraindications for dental and/or surgical treatment are present.

  • The patient is taking medications or having treatments which have an effect on mucosal healing in general (e.g. steroids, large doses of anti-inflammatory drugs).

  • Untreated periodontal conditions

  • Patients not willing to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department fo Stomatology II, Faculty of Medicine and Nursery, University of the Basque Country Leioa Biscay Spain 48940

Sponsors and Collaborators

  • Elena Ruiz de Gopegui Palacios

Investigators

  • Study Director: Luis Antonio Aguirre Zorzano, University of the Basque Country (UPV/EHU)
  • Principal Investigator: Elena Ruiz de Gopegui, University of the Basque Country (UPV/EHU)
  • Principal Investigator: Ana Maria Garcia de la Fuente, University of the Basque Country (UPV/EHU)
  • Study Chair: Ruth Estefania Fresco, University of the Basque Country (UPV/EHU)
  • Study Chair: Xavier Marichalar Mendia, University of the Basque Country (UPV/EHU)
  • Study Chair: Jose Manuel Aguirre Urizar, University of the Basque Country (UPV/EHU)

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Elena Ruiz de Gopegui Palacios, Principal investigator, University of the Basque Country (UPV/EHU)
ClinicalTrials.gov Identifier:
NCT03533933
Other Study ID Numbers:
  • MCP-2
First Posted:
May 23, 2018
Last Update Posted:
Jul 23, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Elena Ruiz de Gopegui Palacios, Principal investigator, University of the Basque Country (UPV/EHU)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 23, 2019